20 Jul Date July 20, 2021 Categories News Phase 2 human clinical trial shows that metabolic activators improve cognitive function in Alzheimer’s disease patients ScandiBio Therapeutics announced Phase 2 clinical trial results from the study “Combined Metabolic Activators Improves Cognitive...
